Challenges for the development of vaccines against Haemophilus influenzae and Neisseria meningitidis

Current Opinion in Immunology

Volumn 14, Issue 5, 2002, Pages 553-557

  Cripps, Allan W ^a   Foxwell, Ruth ^a   Kyd, Jennelle ^a  

^a UNIVERSITY OF CANBERRA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HAEMOPHILUS INFLUENZAE VACCINE; MENINGITIS VACCINE; OUTER MEMBRANE PROTEIN; POLYSACCHARIDE VACCINE; PORIN; PORIN A; PROTEIN D; PROTEIN OMP26; PROTEIN OPC; PROTEIN P5; PROTEIN P6; TETANUS TOXOID; TRANSFERRIN BINDING PROTEIN B; UNCLASSIFIED DRUG;

BACTERIAL FLORA; BACTERIAL IMMUNITY; BACTERIAL MENINGITIS; CONJUGATE; DISEASE COURSE; DRUG EFFICACY; GENETIC VARIABILITY; GENOTYPE; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; INFECTION CONTROL; INFLUENZA; NEISSERIA MENINGITIDIS; PHENOTYPE; REVIEW; SEROTYPE; VACCINATION; VACCINE PRODUCTION;

EID: 0036775782     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(02)00373-4     Document Type: Review

References (33)

1. Centers for Disease Control and Prevention: Haemophilus influenzae Serotype b (Hib) Disease. URL: http://www.cdc.gov/ncidod/dbmd/diseaseinfo/haeminfluserob_t.htm
2. Peltola H. Worldwide Haemophilus influenzae type B disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev. 13:2000;302-317.
3. Dhooge I., Vaneechoutte M., Claeys G., Verschraegen G., van Cauwenberge P. Turnover of Haemophilus influenzae isolates in otitis-prone children. Int J Pediatr Otorhinolaryngol. 54:2000;7-12.
4. Cote S., Sanschagrin F., Dargis M., Simard J.L., Roy P.H., MacDonald N.E., Rabin H.R., Bergeron M.G., Malouin F. Molecular typing of Haemophilus influenzae using a DNA probe and multiplex PCR. Mol Cell Probes. 8:1994;23-37.
5. Morley A.L., Pollard A.J. Vaccine prevention of meningococcal disease, coming soon? Vaccine. 20:2002;666-687.
6. Baker M.G., Martin D.R., Kieft C.E., Lennon D. A 10 year serogroup B meningococcal disease epidemic in New Zealand: descriptive epidemiology, 1991-2000. J Paediatr Child Health. 37:2001;S13-S19.
7. Finne J., Bitter-Suermann D., Goridis C., Finne U. An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues. J Immunol. 138:1987;4402-4407.
8. M'belle N., Huebner R.E., Wasas A.D., Kimura A., Chang I., Klugman K.P. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis. 180:1999;1171-1176.
9. Popovic T., Sacchi C.T., Reeves M.W., Whitney A.M., Mayer L.W., Noble C.A., Ajello G.W., Mostashari F., Bendana N., Lingappa J., et al. Neisseria meningitidis serogroup W135 isolates associated with ET-37 complex. Emerg Infect Dis. 6:2000;428-429.
10. Halsey N.A. Combination vaccines: defining and addressing current safety concerns. Clin Infect Dis. 33:2001;S312-S318.
11. Musser J.M., Barenkamp S.J., Granoff D.M., Selander R.K. Genetic relationships of serologically nontypable and serotype b strains of Haemophilus influenzae. Infect Immun. 52:1986;183-191.
12. Omikunle A., Takahashi S., Ogilvie C., Wang Y., Rodriguez C.A., St Geme J.I.I.I., Adderson E.E. Limited genetic diversity of recent invasive isolates of non-serotype b encapsulated Haemophilus influenzae. J Clin Microbiol. 40:2002;1264-1270.
13. Bayliss C., Field D., Moxon E. The simple sequence contingency loci of Haemophilus influenzae and Neisseria meningitidis. J Clin Invest. 107:2001;657-662.
14. Faden H., Duffy L., Williams A., Krystofic D.A., Wolf J. Epidemiology of nasopharyngeal colonization with nontypeable Haemophilus influenzae in the first two years of life. J Infect Dis. 172:1995;132-135.
15. St Sauver J., Marrs C., Foxman B., Somsel P., Madera R., Gilsdorf J. Risk factors for otitis media and carriage of multiple strains of Haemophilus influenzae and Streptococcus pneumoniae. Emerg Infect Dis. 6:2000;622-630.
16. Weiser J. The generation of diversity by Haemophilus influenzae. Trends Microbiol. 8:2000;433-435.
17. Saunders N., Jeffries A., Peden J., Hood D., Tettelin H., Rappuoli R., Moxon E. Repeat-associated phase variable genes in the complete genome sequence of Neisseria meningitidis strain MC58. Mol Microbiol. 37:2000;207-215.
18. Feil E., Holmes E., Bessen D.E., Chan M.S., Day N.P., Enright M.C., Goldstein R., Hood D.W., Kalia A., Moore C.E., et al. Recombination within natural populations of pathogenic bacteria: Short-term empirical estimates and long-term phylogenetic consequences. Proc Natl Acad Sci USA. 98:2001;182-187.
19. Jelfs J., Munro R., Wedege E., Caugant D. Sequence variation in the porA gene of a clone of Neisseria meningitidis during epidemic spread. Clin Diagn Lab Immunol. 7:2000;390-395.
20. Harvey H., Swords W., Apicella M. The mimicry of human glycolipids and glycosphingolipids by the lipooligosaccharides of pathogenic Neisseria and Haemophilus. J Autoimmun. 16:2001;257-262.
21. Fleischmann R.D., Adams M.D., White O., Clayton R.A., Kirkness E.F., Kerlavage A.R., Bult C.J., Tomb J.-F., Dougherty B.A., Merrick J.M., et al. Whole-genome random sequencing and assembley of Haemophilus influenzae Rd. Science. 269:1995;496-512.
22. Nelson M.B., Munson R.S.J.r, Apicella M.A., Sikkema D.J., Molleston J.P., Murphy T.F. Molecular conservation of the P6 outer membrane among strains of Haemophlius influenzae: analysis of antigenic determinants, gene sequences, and restriction fragment length polymorphisms. Infect Immun. 59:1991;2658-2663.
23. Sirakova T., Kolattukudy P.E., Murwin D., Billy J., Leake E., Lim D., DeMaria T., Bakaletz L. Role of fimbriae expressed by nontypeable Haemophilus influenzae in pathogenesis of and protection against otitis media and relatedness of the fimbrin subunit to outer membrane protein A. Infect Immun. 62:1994;2002-2020.
24. Akkoyunlu M., Ruan M., Forsgren A. Distribution of Protein D, an immunoglobulin D-binding protein in Haemophilus strains. Infect Immun. 59:1991;1231-1238.
25. Haase E.M., Yi K., Morse G.D., Murphy T.F. Mapping of bactericidal epitopes on the P2 porin protein of nontypeable Haemophilus influenzae. Infect Immun. 62:1994;3712-3722.
26. Barenkamp S.J. Immunization with high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae modifies experimental otitis media in chinchillas. Infect Immun. 64:1996;1246-1251.
27. El-Adhami W., Kyd J.M., Bastin D.A., Cripps A.W. Characterisation of the gene for OMP26 from nontypeable Haemophilus influenzae and immune responses to the recombinant protein. Infect Immun. 67:1999;1935-1942.
28. Gu X.X., Sun J., Jin S., Barenkamp S.J., Lim D.J., Robbins J.B., Battey J. Detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins confers protection against otitis media in chinchillas. Infect Immun. 65:1997;4488-4493.
29. Goldschneider I., Gotschlich E.C., Artenstein M.S. Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med. 129:1969;1327-1348.
30. Rosenqvist E., Hoiby E., Wedege E., Bryn K., Kolberg J., Klem A., Ronnild E., Bjune G., Nokleby H. Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine. Infect Immun. 63:1995;4642-4652.
31. Sacchi C., Whitney A., Popovic T., Beall D., Reeves M., Plikaytis B., Rosenstein N., Perkins B., Tondella M., Mayer L. Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998. J Infect Dis. 182:2000;1169-1176.
32. Jolley K.A., Appleby L., Wright J.C., Christodoulides M., Heckels J.E. Immunization with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci. Infect Immun. 69:2001;3809-3816.
33. Rokbi B., Renauld-Mongenie G., Mignon M., Danve B., Poncet D., Chabanel C., Caugant D., Quentin-Millet M. Allelic diversity of the two transferrin binding protein B gene isotypes among a collection of Neisseria meningitidis strains representative of serogroup B disease: implication for the composition of a recombinant TbpB-based vaccine. Infect Immun. 68:2000;4938-4947.